AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial

RecruitingNAAges 18 Years - 60 YearsAllCarsten Dirksen
💬

In plain words

What the trial is, and whether it could suit you

With this trial, the aim is to assess the benefits and harms of a non-surgical intensive weight loss intervention that includes total dietary replacements, behavioural support and weight-loss medication compared with bariatric surgery for people with severe and complex obesity. The interpretation of the results will help inform future care pathways for people with obesity in whom bariatric surgery is currently the only available effective treatment option.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Please note that participants need to be invited in order to take part in the trial. Inclusion Criteria: * Aged 18 to 60 years (inclusive) at time of screening. * Eligible for and willing to undergo bariatric surgery, i.e., fulfilment of criteria for bariatric surgery from the respective national health authorities: * DK: BMI ≥ 35 kg/m2 with one or more of the following: T2D, severe hypertension, sleep apnoea requiring treatment, symptomatic arthrosis in lower extremities, female infertility related to overweight, or BMI\>40 kg/m2 with other strong medical reasons for weight loss (28). Prior to surgery, an 8% weight loss is required as well as smoking cessation. * UK: BMI of 35 kg/m2 to 40 kg/m2 and other significant disease (e.g., type 2 diabetes or high blood pressure), or BMI ≥40 kg/m2. Has been or is willing to receive intensive management in a specialist tier 3 obesity service (29). * Fit for anaesthesia and surgery. * Informed consent. Exclusion Criteria: * Prior bariatric or hiatal surgery, not including intragastric balloons or duodenal-jejunal bypass sleeve (Endobarrier™ or similar) if the device has been removed \>1 year before screening. * Use of any WLM (including liraglutide and semaglutide for diabetes) within last 3 months. * Conditions that contraindicate or complicate total diet replacement (including type 1 diabetes or other diabetes requiring basal bolus insulin therapy or insulin pump therapy (for Denmark) and any diabetes requiring insulin therapy (for UK), phenylketonuria, or other conditions requiring strict adherence to special diets). * Conditions that contraindicate or complicate treatment with GLP-1 receptor analogues (including history of pancreatitis or known allergies). * Conditions that contraindicate or complicate bariatric surgery (GI motility disorders, large abdominal wall hernia, large hiatus hernia (\>5cm), Crohn's disease, liver cirrhosis, or other conditions preventing laparoscopic bariatric surgery e.g. multiple previous abdominal surgery). * Conditions that contraindicate or complicate study adherence and bariatric surgery (mental disorder, unstable psychiatric disease, recent history of alcohol/medication abuse, cancer treatment within 5 years). * Pregnant or planning pregnancy in the next two years or currently breast feeding. * Not achieving a 5% weight loss within 12 weeks prior to randomisation. * People taking part in other research involving multidisciplinary obesity treatment that would compromise their participation in this trial. * Another member of the household enrolled in the trial. * Diagnosis of or treatment for severe eating disorder within the last 6 months.
💊

What it tests

  • Intensive weight loss intervention
  • Bariatric surgery
📍

Where

14 sites
Steno Diabetes Center Aarhus, Aarhus Universitets Hospital
Aarhus, Denmark
The Department of Medicine and Department of Surgery, University Hospital of South West Jutland
Esbjerg, Denmark
The Department of Medicine and the Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre
Hvidovre, Denmark
Department of Surgery, Viborg Regional Hospital
Viborg, Denmark
St Richard's Hospital
Chichester, United Kingdom
Hartlands Hospital, University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
Southmead Hospital, North Bristol NHS Trust
Bristol, United Kingdom
University Hospital Coventry
Coventry, United Kingdom

…and 6 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy